|
ECTE
is EXPLODING and could become a
major acquisition target!
ECTE
is a transdermal medical device company
developing its
needle-free Symphony tCGM System
as a non-invasive, wireless, transdermal continuous
glucose monitoring (tCGM) system and its Prelude
SkinPrep System as a platform technology for transdermal
drug delivery!
ECTE
believes that the Symphony tCGM System will change the
paradigm of invasive, needle-based, pisodic glucose
testing in the diabetes consumer and hospital critical
care markets to one of continuous, needle-free
monitoring.

This is a
MULTI-BILLION
dollar market!!!
ECTE
is also developing its needle-free Prelude SkinPrep
System as a platform technology for enhanced skin
permeation to allow for transdermal drug delivery of a
wide range of FDA-approved products!
ECTE
believes that the Symphony system is an ideal solution
for diabetics and critically ill patients allowing for
continuous, pain-free monitoring of glucose levels.
The continuous monitoring will enable
more accurate management of diabetes (resulting in
healthier outcomes) and higher compliance compared to
painful, invasive methods for drawing blood today.
ECTE
also believes that its Prelude SkinPrep System will
allow many drugs currently delivered by needle injection
to be administered without a needle by using Prelude
prior to transdermal drug administration.
This alone could add substantial value to
ECTE
in the short-term!
----------------------------------
ECTE's $15 Million Agreement
ECTE has signed a
$15 million agreement,
giving Ferndale Pharmaceuticals a license to develop,
market and sell Prelude for enhanced delivery of
Ferndales topical lidocaine product, LMX4, in North
America and the UK. Echo received $750,000 up front and
will receive $750,000 upon FDA approval, as well as
$12.5 million in milestones and guaranteed minimum
royalty payments. Echo will also receive a double digit
royalty on net sales of the product.
ECTE
could really start top breakout over the next couple of
days so start your research tonight and get ready for a
big day tomorrow!
|